ROC Curve Analysis of the Sensitivity and Specificity of Biochemical Detection of Intrahepatic Cholestasis during Pregnancy

Xiaoyi Huang; Siyi Chen; Hongyan Chen; Liang Hu; Lijuan Wen; Fengxiang Wei; Ken Chen

doi:10.1055/a-1299-2298

Zeitschrift für Geburtshilfe und Neonatologie, Table of Contents

Z Geburtshilfe Neonatol 2021; 225(04): 327-332
DOI: 10.1055/a-1299-2298

Original Article

ROC Curve Analysis of the Sensitivity and Specificity of Biochemical Detection of Intrahepatic Cholestasis during Pregnancy

Xiaoyi Huang

¹Guangdong Pharmaceutical University, School of Nursing, Guangdong Pharmaceutical University, Guangzhou, Guangzhou, China

,

Siyi Chen

¹Guangdong Pharmaceutical University, School of Nursing, Guangdong Pharmaceutical University, Guangzhou, Guangzhou, China

,

Hongyan Chen

¹Guangdong Pharmaceutical University, School of Nursing, Guangdong Pharmaceutical University, Guangzhou, Guangzhou, China

,

Liang Hu

²Shenzhen Longgang District Maternity & Child Healthcare Hospital of Shenzhen City, Shenzhen, China

,

Lijuan Wen

²Shenzhen Longgang District Maternity & Child Healthcare Hospital of Shenzhen City, Shenzhen, China

,

Fengxiang Wei

²Shenzhen Longgang District Maternity & Child Healthcare Hospital of Shenzhen City, Shenzhen, China

,

Ken Chen

¹Guangdong Pharmaceutical University, School of Nursing, Guangdong Pharmaceutical University, Guangzhou, Guangzhou, China

› Author Affiliations

Abstract

Introduction Intrahepatic cholestasis of pregnancy (ICP) is associated with an increased risk of adverse pregnancy outcomes in mothers and infants. The aim was to evaluate the sensitivity and specificity of biochemical detection of ICP by ROC curve and to determine the threshold of more reliable experimental indicators.

Materials and Methods 305 patients and 305 healthy pregnant women were enrolled in the study.

Results The average levels of TBA, ALT, and AST in the ICP group were much higher than those in the control group (P<0. 001); the area of both CG and TBA under ROC curve was up to 0.99, the sensitivity was 97.7%, and the specificity was 99.3%.

Conclusions This study did not find any single specificity and sensitivity markers that could be used to reliably diagnose ICP. In the future, we will pay more attention to the correlation between sensitive biochemical indicators and adverse pregnancy outcomes.

Keywords

intrahepatic cholestasis of pregnancy - diagnostics - roc curve

Full Text

References

References
1 Antonín Pařízek, Martin Hill, Michaela Dušková. et al. A comprehensive evaluation of steroid metabolism in women with intrahepatic cholestasis of pregnancy. PLoS ONE 2016; 11: e0159203 10.1371/journal.pone.0159203
2 Niharika Mehta, Chen Kenneth K, George Kroumpouzos. Skin disease in pregnancy: the approach of the obstetric medicine physician. Clin Dermatol 2016; 34: 320-326 doi:10.1016/j.clindermatol.2016.02.003
3 Wood Amber M, Livingston Elizabeth G, Hughes Brenna L. et al. Intrahepatic cholestasis of pregnancy: a review of diagnosis and management. Obstet Gynecol Surv 2018; 73: 103-109 10.1097/OGX. 0000000000000524
4 Caroline Ovadia, Catherine Williamson. Intrahepatic cholestasis of pregnancy: recent advances. Clin Dermatol 2016; 34: 327-334 doi:10.1016/j.clindermatol.201 6.02.004
5 Ovadia C, Seed PT, Sklavounos A. et al. Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses. Lancet 2019; 393: 899-909 10.1016/S0140-6736(18)31877-4
6 Chiang JYL, Ferrell JM. Bile acids as metabolic regulators and nutrient sensors. J Annu Rev Nutr 2019; 39: 175-200 doi:10.1146/annurev-nutr-082018-124344
7 Yeap SP, Harley H, Thompson R. et al. Biliary transporter gene mutations in severe intrahepatic cholestasis of pregnancy: diagnostic and management implications. J Gastroenterol Hepatol 2019; 34: 425-435 10.111/jgh.14376
8 Wensink MJ. The risk of infant and fetal death by each additional week of expectant management in intrahepatic cholestasis of pregnancy by gestational age: various objections. Am J Obstet Gynecol 2016; 215: 807-808 doi:10.1016/j.ajog.2 016.07.033
9 Wang L, Lu Z, Zhou X. et al. Effects of intrahepatic cholestasis of pregnancy on hepatic function, changes of inflammatory cytokines and fetal outcomes. Exp Ther Med 2019; 17: 2979-2984 10.3892/etm.2019.7312
10 Palmer KR, Xiaohua L, Mol BW. Management of intrahepatic cholestasis in pregnancy. Lancet 2019; 393: 853-854 doi:10.1016/s01406736(18)32323-7
11 Bicocca MJ, Sperling JD, Chauhan SP. Intrahepatic cholestasis of pregnancy: review of six national and regional guidelines. Eur J Obstet Gynecol Reprod Biol 2018; 231: 180-187 doi:10.1016/j.ejogrb.2018.10.041
12 Floreani A, Gervasi MT. New insights on intrahepatic cholestasis of pregnancy. Clin Liver Dis 2016; 20: 177-189 doi:10.1016/j.cld.2015.08.010
13 Celik S, Caliskan CS, Celik H. et al. Predictors of adverse perinatal outcomes in intrahepatic cholestasis of pregnancy. J Ginekologia polska 2019; 90: 217-222 10.5603/gp.2019.0039
14 Bechtel MA. Pruritus in pregnancy and its management. Dermatol Clin 2018; 36: 259-265 10.1016/j.det.2018.02.012
15 Di Mascio D, Quist-Nelson J, Riegel M. et al. Perinatal death by bile acid levels in intrahepatic cholestasis of pregnancy: a systematic review. J Matern Fetal Neonatal Med. 2019 10.1080/14767058.2019.1685965
16 Garcia-Romero CS, Guzman C, Cervantes A. et al. Liver disease in pregnancy: medical aspects and their implications for mother and child. Ann Hepatol 2019; 18: 553-562 10.1016/j.aohep.2019.04.009
17 Yayla AC, Vural F, Kilicci C. et al. Can we predict severity of intrahepatic cholestasis of pregnancy using inflammatory markers?. Turk J Obstet Gynecol 2017; 14: 160-165 10.4274/tjod.67674
18 de Seymour JV, Tu S, He X. et al. Metabolomic profiling of maternal hair suggests rapid development of intrahepatic cholestasis of pregnancy. Metabolomics 2018; 14: 79 10.1007/s11306-018-1371-7
19 Zou P, Luo L, Zhao C. et al. The serum microRNA profile of intrahepatic cholestasis of pregnancy: identification of novel noninvasive biomarkers. Cell Physiol Biochem 2018; 51: 1480-1488 10.1159/000495595
20 Zhu B, Yin P, Ma Z. et al. Characteristics of bile acids metabolism profile in the second and third trimesters of normal pregnancy. Metabolism 2019; 95: 77-83 10.1016/j.metabol.2019.04.004
21 Mei Y, Lin Y, Luo D. et al. Perinatal outcomes in intrahepatic cholestasis of pregnancy with monochorionic diamniotic twin pregnancy. BMC Pregnancy Childbirth 2018; 18: 291 10.1186/s12884-018-1913-z
22 Pahlitzsch TMJ, Hanne L, Henrich W. et al. Influence of Foetal Macrosomia on the Neonatal and Maternal Birth Outcome. Geburtshilfe Frauenheilkd 2019; 79: 1191-1198 10.1055/a-0880-6182
23 Ekiz A, Kaya B, Avci ME. et al. Alanine aminotransferase as a predictor of adverse perinatal outcomes in women with intrahepatic cholestasis of pregnancy. Pak J Med Sci 2016; 32: 418-422 10.12669/pjms.322.9057
24 Zhu P, Zhao SM, Li YZ. et al. Correlation of lipid peroxidation and ATP enzyme on erythrocyte membrane with fetal distress in the uterus in patients with intrahepatic cholestasis of pregnancy. Eur Rev Med Pharmacol Sci 2019; 23: 2318-2324 10.26355/eurrev_201903_17371
25 Manna LB, Ovadia C, Lovgren-Sandblom A. et al. Enzymatic quantification of total serum bile acids as a monitoring strategy for women with intrahepatic cholestasis of pregnancy receiving ursodeoxycholic acid treatment: a cohort study. BJOG 2019; 126: 1633-1640 10.1111/1471-0528.15926
26 Çelik S, Çalışkan C. The impact of assisted reproductive technology in twin pregnancies complicated by intrahepatic cholestasis of pregnancy: a retrospective cohort study. Z Geburtshilfe Neonatol 2020;